finanzen.net
20.02.2019 17:15
Bewerten
(0)

Global Human Immunodeficiency Virus (HIV) Drugs Market 2019-2025 with AbbVie, Merck, Gilead Sciences, Bristol-Myers Squibb, Janssen & GSK Dominating

DRUCKEN

DUBLIN, Feb. 20, 2019 /PRNewswire/ --

The "Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 - 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts" report has been added to ResearchAndMarkets.com's offering.

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025.

The report presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscape, and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for global human immunodeficiency virus (HIV) drugs market. The report includes historical data from 2015 to 2018, and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global human immunodeficiency virus (HIV) drugs market. The report explores detailed analysis of top 22 HIV drugs market assessment globally from 2015 to 2018 and forecasts to 2025. The report also details the latest happenings about the global research & development of HIV drugs.

Additionally, the report includes an assessment of clinical trials and promising human immunodeficiency virus (HIV) drugs in clinical development. Key trends in terms of collaboration, partnerships, and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the global human immunodeficiency virus (HIV) drugs market.

The report concludes with the profiles of major players in the global human immunodeficiency virus (HIV) drugs market. The key market players are evaluated on various parameters such as business overview and recent development.

The Major Companies Dominating this Market for its Drugs, Services and Continuous Drugs Developments are:

  • AbbVie
  • Merck
  • Gilead Sciences
  • Bristol-Myers Squibb
  • Janssen (Johnson&Johnson)
  • GlaxoSmithKline (GSK)

Top 22 Human Immunodeficiency Virus (HIV) Drugs Covered Under this Report are:

  • Tivicay
  • Triumeq
  • Juluca
  • Epzicom
  • Selzentry
  • Kaletra
  • Sustiva
  • Reyataz
  • Atripla
  • Truvada
  • Viread
  • Complera
  • Stribild
  • Genvoya
  • Biktarvy
  • Descovy
  • Odefsey
  • Prezista/Prezcobix
  • Edurant
  • Isentress
  • Pifeltro
  • Delstrigo

The Latest Industry Data Included in this Report:

  • Global HIV Drugs Market Size & Analysis (2015 - 2025)
  • Global HIV Drugs Market Share & Y-o-Y Growth (%),2015 - 2025
  • Global Top 22 HIV Drugs Market Assessment & Opportunity (2015 - 2025)
  • Promising HIV Drugs in Clinical Development
  • HIV Drugs Clinical Trial Insight by Phase, Institute & Country,2018
  • Major Deals (Key Agreements, Partnerships & Collaborations)
  • Latest Happenings in Global HIV Drugs Market
  • Key Drivers & Inhibitors of the Global HIV Drugs Market
  • Major Companies Analysis

The Answers to the Following Key Questions can be found in the Report:

  • What is the size of the global HIV drugs market during 2015 -2025?
  • What will be the revenue generated by each drug during the forecast period?
  • Which major drug provides the highest market share?
  • How are the overall market and major drugs growing?
  • What are the key drivers and inhibitors in the current market?
  • What will be the impact of drivers and inhibitors in the future?
  • How is the market predicted to develop in the future?
  • Who are the key players in this market space?

For more information about this report visit https://www.researchandmarkets.com/research/8wj78d/global_human?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-human-immunodeficiency-virus-hiv-drugs-market-2019-2025-with-abbvie-merck-gilead-sciences-bristol-myers-squibb-janssen--gsk-dominating-300798876.html

SOURCE Research and Markets

Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX geht tiefrot ins Wochenende -- Commerzbank-Chef liebäugelt mit Fusion -- Chaos-Brexit vorerst abgewendet -- Deutsche-Bank: Renditeziel für 2019 bestätigt -- Nike, Ströer, Uber, Dürr, Hapag im Foku

Allianz bietet auf Versicherungs-Sparten von BBVA. Nokia-Warnung vor Problemen bei Alcatel-Zukauf sorgen Anleger. ProSiebenSat.1-Aktie vor Mehrjahrestief. Rendite zehnjähriger Bundesanleihen erstmals seit Herbst 2016 wieder negativ. Neuer Videodienst von Apple erwartet. RWE und E.ON im Aufwind.

Die 5 beliebtesten Top-Rankings

Die zehn größten Kapitalvernichter
Hier wurde am meisten Anlegergeld verbrannt
DIe innovativsten Unternehmen
Diese Unternehmen sind am fortschrittlichsten
Die Top-Autos des Genfer Autosalon 2019
Das sind die Highlights
Das hat sich geändert
Diese Aktien hat George Soros im Depot
Diese Aktien hat Warren Buffett im Depot
Einige Änderungen unter den Top-Positionen
mehr Top Rankings

Umfrage

Nun ist es bestätigt: Deutsche Bank und Commerzbank loten offiziell eine Fusion aus. Glauben Sie, dass es tatsächlich dazu kommen wird?

finanzen.net Brokerage

Online Brokerage über finanzen.net

Das Beste aus zwei Welten: Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus der Informationswelt von finanzen.net!
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Wirecard AG747206
Deutsche Bank AG514000
BayerBAY001
CommerzbankCBK100
Apple Inc.865985
Daimler AG710000
Amazon906866
Aurora Cannabis IncA12GS7
Deutsche Telekom AG555750
E.ON SEENAG99
BASFBASF11
Siemens AG723610
NEL ASAA0B733
EVOTEC AG566480
Volkswagen (VW) AG Vz.766403